Read + Share
Lee CH, Voss MH, Carlo MI, Chen YB, et al. Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non-Clear-Cell
Renal Cell Carcinoma and Genomic Correlates. J Clin Oncol 2022;40:2333-2341.
PMID: 35298296
|
 |
|
Lee CH, Voss MH, Carlo MI, Chen YB, et al. Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non-Clear-Cell
Renal Cell Carcinoma and Genomic Correlates. J Clin Oncol 2022;40:2333-2341.
PMID: 35298296
|
|
|
|